• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利多中心研究:伊曲康唑、伏立康唑、两性霉素B和卡泊芬净对多种菌种的“体外活性”:Sensititre YeastOne与MIC测试条的比较

Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Species: Comparison between Sensititre YeastOne and MIC Test Strip.

作者信息

Lo Cascio Giuliana, Bazaj Alda, Trovato Laura, Sanna Silvana, Andreoni Stefano, Blasi Elisabetta, Conte Marco, Fazii Paolo, Oliva Ester, Lepera Valentina, Lombardi Gianluigi, Farina Claudio

机构信息

Clinical Microbiology and Virology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Medical Mycology Committee, Italian Society of Clinical Microbiologist, Milan, Italy.

出版信息

Infect Drug Resist. 2022 Oct 4;15:5839-5848. doi: 10.2147/IDR.S367082. eCollection 2022.

DOI:10.2147/IDR.S367082
PMID:36217342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9547591/
Abstract

In this study the activity of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin against 224 clinical isolates of spp. originating from seven Italian hospitals, was comparatively evaluated with two commercial antifungal susceptibility tests (AST): Sensititre YeastOne (SYO) and MIC Test Strip. More attention was focused on Isavuconazole activity, given the new introduction of the drug in widely distributed antifungal susceptibilities methods in the clinical microbiology lab. The minimum inhibitory concentrations of antifungal drug that can inhibit the growth of pathogen by 90% (MIC90) for Isavuconazole detected by SYO were 0.5, 1, 0.25, and 2 µg/mL for , , , and , respectively, whilst they were 0.25, 0.25, 0.5, and 0.75 µg/mL by MIC Test Strip. Essential agreement between the two tested methods for Isavuconazole is 70% for all the species tested, 75.7% for , 45.2% for , 90.6% for . , and 40% for . Although the tested strains do not express any phenotypic resistance, MIC results were quite different if tested with microdilution broth or gradient agar method. This is the first Italian multicenter report on Isavuconazole MIC obtained employing the widely used Sensititre Yeast One (SYO) and MIC Test Strip on clinical isolates of .

摘要

在本研究中,使用两种商业抗真菌药敏试验(AST):Sensititre YeastOne(SYO)和MIC试纸条,对源自意大利七家医院的224株临床分离菌的伊曲康唑、伏立康唑、两性霉素B和卡泊芬净活性进行了比较评估。鉴于该药物新引入临床微生物实验室广泛使用的抗真菌药敏方法中,所以对伊曲康唑活性给予了更多关注。通过SYO检测,伊曲康唑对、、、和的能抑制病原体生长90%的最低抑菌浓度(MIC90)分别为0.5、1、0.25和2μg/mL,而通过MIC试纸条检测时分别为0.25、0.25、0.5和0.75μg/mL。两种检测方法对伊曲康唑的基本一致性,对于所有测试菌种为70%,对于为75.7%,对于为45.2%,对于为90.6%,对于为40%。尽管测试菌株未表现出任何表型抗性,但如果用微量稀释肉汤法或梯度琼脂法测试,MIC结果差异很大。这是意大利第一份关于使用广泛应用的Sensititre Yeast One(SYO)和MIC试纸条对临床分离菌进行伊曲康唑MIC检测的多中心报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46aa/9547591/adea8938b269/IDR-15-5839-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46aa/9547591/333190939d67/IDR-15-5839-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46aa/9547591/adea8938b269/IDR-15-5839-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46aa/9547591/333190939d67/IDR-15-5839-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46aa/9547591/adea8938b269/IDR-15-5839-g0002.jpg

相似文献

1
Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Species: Comparison between Sensititre YeastOne and MIC Test Strip.意大利多中心研究:伊曲康唑、伏立康唑、两性霉素B和卡泊芬净对多种菌种的“体外活性”:Sensititre YeastOne与MIC测试条的比较
Infect Drug Resist. 2022 Oct 4;15:5839-5848. doi: 10.2147/IDR.S367082. eCollection 2022.
2
Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.比较 Sensititre YeastOne 和 CLSI M38-A2 微量稀释法测定两性霉素 B、伊曲康唑、伏立康唑和泊沙康唑对曲霉属的活性。
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00780-18. Print 2018 Oct.
3
Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for Antifungal Susceptibility Testing of Cryptococcus neoformans.新型隐球菌药敏试验中 MIC 测试条和 Sensititre YeastOne 与 CLSI 和 EUCAST 肉汤微量稀释参考方法的比较。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02261-19.
4
In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.188 株临床和环境黄曲霉分离株对新型三唑类药物伊曲康唑及其他七种抗真菌药物的体外药敏试验。
Mycoses. 2011 Sep;54(5):e583-9. doi: 10.1111/j.1439-0507.2010.01996.x. Epub 2011 Apr 25.
5
Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species.用于曲霉属和赛多孢属菌种药敏试验的艾沙康唑MIC试纸条评估。
Med Mycol. 2019 Jun 1;57(4):429-433. doi: 10.1093/mmy/myy071.
6
Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratories.评估 Sensititre YeastOne 药敏板对临床相关酵母和霉菌种属进行伊曲康唑和其他抗真菌药物敏感性检测的性能,该药敏板在澳大利亚的三个诊断真菌学实验室进行了研究。
Pathology. 2022 Dec;54(7):922-927. doi: 10.1016/j.pathol.2022.05.006. Epub 2022 Jul 3.
7
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in and Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.基于方法学的流行病学折点值用于检测色原性 YeastOne 比浊法和 Etest 琼脂扩散法检测 和 种属中唑类药物耐药性。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01651-18. Print 2019 Jan.
8
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.曲霉属真菌对伏立康唑、伊曲康唑、泊沙康唑、两性霉素 B 和卡泊芬净的体外药敏试验。
Chin Med J (Engl). 2010 Oct;123(19):2706-9.
9
Comparative evaluation of Sensititre YeastOne and CLSI M38-Ed3 reference method for determining echinocandin minimum effective concentrations against isolates.棘白菌素最低有效浓度检测方法的比较评估:Sensititre YeastOne 与 CLSI M38-Ed3 参考方法对 株的应用。
Microbiol Spectr. 2024 Oct 3;12(10):e0028024. doi: 10.1128/spectrum.00280-24. Epub 2024 Aug 20.
10
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.泊沙康唑、雷夫康唑和伏立康唑与伊曲康唑及两性霉素B相比,对239株曲霉属及其他丝状真菌临床分离株的抗真菌活性:2000年SENTRY抗菌监测项目报告
Antimicrob Agents Chemother. 2002 Apr;46(4):1032-7. doi: 10.1128/AAC.46.4.1032-1037.2002.

引用本文的文献

1
Novel Antifungals and Section with Potpourri Susceptibility Profiles to Conventional Antifungals.新型抗真菌药物以及对传统抗真菌药物具有混合药敏谱的部分。
J Fungi (Basel). 2023 Jun 6;9(6):649. doi: 10.3390/jof9060649.
2
Section and Antifungals: From Broth to Agar-Based Susceptibility Testing Methods.章节与抗真菌药物:从肉汤到基于琼脂的药敏试验方法
J Fungi (Basel). 2023 Feb 27;9(3):306. doi: 10.3390/jof9030306.

本文引用的文献

1
Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of sections and .临床相关及隐匿种的分子鉴定和抗真菌药敏性研究
J Med Microbiol. 2022 Apr;71(4). doi: 10.1099/jmm.0.001480.
2
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions.新型冠状病毒肺炎相关肺曲霉病的患病率:批判性综述与结论
J Fungi (Basel). 2022 Apr 12;8(4):390. doi: 10.3390/jof8040390.
3
Azole resistance in Aspergillus fumigatus. The first 2-year's Data from the Danish National Surveillance Study, 2018-2020.
烟曲霉唑类耐药性。2018-2020 年丹麦全国监测研究的头两年数据。
Mycoses. 2022 Apr;65(4):419-428. doi: 10.1111/myc.13426. Epub 2022 Feb 8.
4
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021.侵袭性曲霉病诊断与管理共识指南,2021 年版。
Intern Med J. 2021 Nov;51 Suppl 7:143-176. doi: 10.1111/imj.15591.
5
Echinocandins and Their Activity against Aspergillus terreus Species Complex: a Novel Agar Screening Method.棘白菌素类及其对土曲霉复合体的活性:一种新型琼脂筛选方法。
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0190921. doi: 10.1128/AAC.01909-21. Epub 2021 Dec 13.
6
An Under-recognized Cause of Antifungal Drug-Resistant Aspergillosis.一种未被充分认识的耐抗真菌药曲霉病病因。
Open Forum Infect Dis. 2021 Aug 29;8(8):ofab392. doi: 10.1093/ofid/ofab392. eCollection 2021 Aug.
7
Invasive pulmonary aspergillosis associated with viral pneumonitis.侵袭性肺曲霉病合并病毒性肺炎。
Curr Opin Microbiol. 2021 Aug;62:21-27. doi: 10.1016/j.mib.2021.04.006. Epub 2021 May 23.
8
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病:2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
9
Updated EUCAST Clinical Breakpoints against , Implications for the Clinical Microbiology Laboratory.针对……的更新后的欧盟CAST临床断点,对临床微生物实验室的影响。 (你提供的原文“against”后面缺少具体内容,以上翻译是根据现有内容尽量完善后的结果)
J Fungi (Basel). 2020 Dec 6;6(4):343. doi: 10.3390/jof6040343.
10
Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.基于琼脂的曲霉属棘白菌素敏感性筛选方法的开发和多中心验证。
J Antimicrob Chemother. 2019 Aug 1;74(8):2247-2254. doi: 10.1093/jac/dkz154.